Impact of a Cognitive Intervention Enriched With Leisure Activities in Persons With Subjective Cognitive Decline
1 other identifier
interventional
144
1 country
2
Brief Summary
The team "Cognitive intervention, cognitive reserve and brain plasticity", Team 10, is part of the Canadian Consortium on Neurodegeneration in Aging (CCNA). The team's aim is to develop and test a multi-faceted intervention program meant to increase cognitive and brain reserve by providing cognitive stimulation through participation in cognitive training sessions and engaging leisure activities. This will be done with a partially randomized controlled double-blind preference trial with a comprehensive cohort design, in participants with subjective cognitive decline (SCD) recruited in Montreal and Toronto.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2016
CompletedFirst Posted
Study publicly available on registry
September 5, 2017
CompletedStudy Start
First participant enrolled
September 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMarch 17, 2026
March 1, 2026
4.8 years
December 15, 2016
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in episodic memory (composite score)
A composite score will be computed by averaging z-scores from the delayed recall of the Rey Auditory Verbal Learning Test (RAVLT) and the delayed recall of the face-name association task (an associative memory test adapted from Simona Brambati's task for the Consortium pour l'Identification precoce de la Maladie d'Alzheimer (CIMA-Q) study currently running in Quebec).
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
Secondary Outcomes (8)
Changes in attention control (composite score)
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
Changes in psychological health: Anxiety and depression (composite score)
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
Changes in psychological health: Apathy
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
Changes in psychological health: Quality of life (composite score)
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
Changes in psychological health: Help-seeking behaviour
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
- +3 more secondary outcomes
Other Outcomes (7)
Transfer to everyday life (self-reported): Meta-memory rating
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
Transfer to everyday life (self-reported): Attention and recent memory rating
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
Transfer to everyday life (self-reported): Activities of daily living
PRE (within 12 weeks before intervention starts) + POST-1 (within 8 weeks after the end of intervention) + POST-2 (2 years from PRE, +/- 3 months)
- +4 more other outcomes
Study Arms (2)
ENGAGE SPANISH/MUSIC
EXPERIMENTALCognitive strategies to improve attention and memory skills and application in selected leisure activities (music or Spanish lessons, and videogames) over 4 months.
ENGAGE DISCOVERY
ACTIVE COMPARATOREducational program about brain and healthy aging complemented by learning of new information with videogames, documentaries and group discussions over 4 months.
Interventions
Cognitive strategies to improve attention and memory skills (21 hours), leisure activities (music lessons or Spanish lessons) (27 hours), selected videogames to practice variable attention strategies (4 hours in class + about 10 hours at home). Total of 24 2-hour in class sessions over 4 months. The training will be delivered to small groups of 5 to 8 participants by a trained therapist for formal sessions and a professional music or Spanish teacher for leisure sessions.
Educational content about brain and healthy aging (21 hours), leisure activities (watching documentaries followed by group discussion and debate) (27 hours), selected non-stimulating videogames (4 hours in class + about 10 hours at home). Total of 24 2-hour in class sessions over 4 months. The training will be delivered to small groups of 5 to 8 participants by the same trained therapist as in the ENGAGE arm.
Eligibility Criteria
You may qualify if:
- Possess sufficient visual and auditory acuity to undergo neuropsychological tests and to do the intervention.
- Commit for the whole intervention + 2 follow-up sessions 2 years from pre-test.
- Have an internet connection at home.
- Answer 'Yes' to both following questions: "Do you feel like your memory is becoming worse?" "Does this worry you?"
- Have a delayed recall score above the education-adjusted cut-offs (≥9 for 16+ years of education; ≥5 for 8-15 years of education; ≥3 for 0-7 years of education) at the Logical Memory test (Wechsler Memory Scale, maximum score 25).
- Have a Montreal Cognitive Assessment (MoCA) total score of 20 and above (≥20/30).
- Have a delayed recall score at the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Word List task above 4 (\>4).
- Have a global Clinical Dementia Rating score (CDR) equal to 0 or 0.5 (=0 to 0.5).
You may not qualify if:
- The presence of disease or injury of the central nervous system, such as: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, subdural hematoma (past or current), subarachnoid haemorrhage (past or current), primary cerebral tumour or cerebral metastases, epilepsy (current), dementia or another neurodegenerative disease, and other rarer brain illnesses.
- Symptomatic stroke within the previous year.
- History of intracranial surgery.
- Major surgery within last 2 months.
- Serious comorbid condition that, in the opinion of the study investigator, is likely to result in death within a year.
- Major depression or anxiety.
- Schizophrenia or other major psychiatric disorder.
- Ongoing alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures.
- Subject does not have a study partner who can provide corroborative information.
- Individuals where English (Toronto) or French (Montreal) is not sufficiently proficient for clinical assessment and neuropsychological testing.
- Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure.
- Plans on moving outside the province within the next 2 years.
- Musicianship: more than 5 years of formal music training in total life or more than 10 years of choir experience.
- Fluency in Spanish: has learned Spanish after secondary school for more than 5 years, speaks Spanish at home, has ever lived in a Hispanic country.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Rotman Research Institute, Baycrest
Toronto, Ontario, M6A 2E1, Canada
CRIUGM
Montreal, Quebec, h3w 1w4, Canada
Related Publications (1)
Belleville S, Moussard A, Ansaldo AI, Belchior P, Bherer L, Bier N, Bohbot VD, Bruneau MA, Cuddy LL, Gilbert B, Jokel R, Mahalingam K, McGilton K, Murphy KJ, Naglie G, Rochon E, Troyer AK, Anderson ND. Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaint. Trials. 2019 May 22;20(1):282. doi: 10.1186/s13063-019-3250-6.
PMID: 31118095DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvie Belleville, PhD
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D, Full professor, University of Montreal, and Scientific Director, Institut Universitaire de Geriatrie de Montreal (IUGM)
Study Record Dates
First Submitted
December 15, 2016
First Posted
September 5, 2017
Study Start
September 15, 2017
Primary Completion
June 30, 2022
Study Completion (Estimated)
June 30, 2026
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share